Baltimore startup Vita Therapeutics raises $31M to advance treatment for genetic diseases
The round will help Vita Therapeutics prepare for a human clinical trial for a treatment for a form of muscular dystrophy.
Wednesday, October 12, 2022 at 5:02 pm